Henning Schneider

Partner at Latham & Watkins and President of the American Chamber of Commerce, Northern Chapter.

Henning Schneider

Partner at Latham & Watkins and President of the American Chamber of Commerce, Northern Chapter.

Biography

Dr. Henning C. Schneider is a partner in the Hamburg office of Latham & Watkins, Co-chair of the German Corporate Department and Chair of the firm’s global Healthcare Industry Group. He is member of several supervisory boards and President of the American Chamber of Commerce, Northern Chapter. Mr. Schneider is an Alumnus of the German National Academic Foundation (Studienstiftung des Deutschen Volkes).

He focuses on advising international and national corporates, PE investors and public organizations on

  • M&A/PE transactions
  • Joint ventures, Restructurings, Carve-outs and Privatizations

He offers broad industry expertise in Healthcare/Life Sciences, Financial Services, Infrastructure, Automotive, Real Estate and Energy/Cleantech.

Mr. Schneider led the team on Rhön-Klinikum’s €3 billion sale of major assets to Fresenius/Helios, which was honored by The Lawyer as “European Corporate Deal of the Year 2015.” Financial Times European Lawyers Awards 2014 listed him as one of the “Top 10 Legal Innovators of the Year in Europe” and he is one of the “best lawyers” for Corporate/M&A in Germany (Handelsblatt Best Lawyers 2016).

JUVE 2016/2017 lists Mr. Schneider as a “recommended lawyer” for M&A, Corporate Law and Healthcare. Clients are “very impressed” (2013/2014). He is also praised for his “excellent and timely advice” and as “highly competent, flexible, thinks strategically and has pronounced commercial understanding” (2012/2013).

Chambers Europe Germany also recognizes him as a “key individual” for M&A and Healthcare and considers him as “one of the most important advisers for hospital deals” (2016). Clients praise: “He has a deep knowledge of corporate law, but also the mindset to understand clients’ commercial needs” (2015). Furthermore, “he has a very deep knowledge of all questions of legal importance in a transaction – he concentrates on the sector, so you don’t have to start from zero when you work together” (2014).

The Legal 500 mentions his “impressive presence in large transactions in healthcare and life sciences,” praises the “high-profile team around Henning Schneider” (Germany 2014) and names him “a heavyweight both in legal terms as well as in strategy” (EMEA 2013).

All session by Henning Schneider

Innovation and Investment panel

11:15 - 12:15
Main Stage